Medifast inadvertently discloses internal target of flat revenue for FY2024; cautions not guidance

MEDIFAST INC

Internal target set in early 2023 anticipated flat revenue growth for FY2024.
Disclosure made inadvertently at an investor meeting on September 26, 2023.
Company emphasizes no final 2024 forecast yet; target subject to uncertainties.
Filed under Regulation FD to address inadvertent disclosure; no formal guidance intended.
Forward-looking statements caution numerous risks; no reliance should be placed on target.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.